| 
News Releases are added to our web site as soon as possible after release to the general public and/or the Exchange. If you would like to receive news releases via e-mail or fax, please fill out the Request More Info form. (The news releases here are just the highlights. For a complete listing of all corporate filings, click here for the free SEDAR database)
|
Fri Aug 1, 2008
Functional Technologies Announces Change to Investor Relations Program
VANCOUVER, BRITISH COLUMBIA --- August 1, 2008 --- Functional Technologies Corp. (TSXV: FEB) today announced the termination of its investor relations agreement with Ascenta Capital Partners Inc. effective August 28, 2008.
"We would like to thank Ascenta for their professionalism and commitment to Functional Technologies during the tenure of our investor relations agreement," commented Howard Louie, CEO of Functional Technologies.
About Functional Technologies Corp.
Functional Technolog... (2 KB) |
|
Thu Jul 24, 2008
Functional Technologies Acquires Product Development and Laboratory Facility
VANCOUVER, BRITISH COLUMBIA --- July 24, 2008 --- Functional Technologies Corp. (TSXV: FEB) is pleased to announce the purchase of a product development and laboratory facility in Prince Edward Island (PEI). The facility will provide Functional Technologies the capability of testing intermediate production volumes for its Phyterra Yeast and Phyterra Bio products, and will act as a bridge between the laboratory bench top and full scale commercial production.
The 36,000 square foot building is l... (4 KB) |
|
Wed Jul 23, 2008
Functional Technologies Plans Rights Offering
VANCOUVER, BRITISH COLUMBIA --- July 23, 2008 --- Functional Technologies Corp. (TSXV: FEB) announces that it will be filing with applicable securities regulatory authorities in Canada and the TSX Venture Exchange relevant materials to commence an offering of units (the "Units") by way of a rights offering. Subject to regulatory approval, Functional Tec... (5 KB) |
|
Tue Jul 22, 2008
Functional Technologies Announces Launch of Phyterra Bio Subsidiary Provides Guidance on New Product Development
VANCOUVER, BRITISH COLUMBIA --- July 22, 2008 --- Functional Technologies Corp. (TSXV: FEB) is pleased to announce the launch of its new Phyterra Bio Inc. subsidiary based in Prince Edward Island (PEI). Phyterra Bio will be responsible for the development of the portfolio of proprietary assets acquired by Functional Technologies through its 2007 acquisition of Phycobiologics Inc.
Phyterra Bio will focus on the development of novel health care products derived from the micro-algae, Chlamydom... (7 KB) |
|
Mon Jul 21, 2008
Functional Technologies Provides Update on Yeast Business
VANCOUVER, BRITISH COLUMBIA --- July 21, 2008 --- Functional Technologies Corp. (TSXV: FEB) is pleased to announce that it has secured the first commercial production inventory of its urea-degrading Phyterra Yeast products, which have been proven to substantially reduce the formation of ethyl carbamate (also known as urethane) in fermented foods and beverages. Ethyl carbamate is classified by the World Health Organization as a Group 2A carcinogen - the same carcinogen class as lead, mercury, ac... (5 KB) |
|
Tue Jun 17, 2008
Functional Technologies Hires New Chief Scientific Officer
VANCOUVER, BRITISH COLUMBIA -- June 17, 2008 -- Functional Technologies Corp. (TSXV: FEB) is pleased to announce the appointment of Michael Horne, PhD., as Chief Scientific Officer of the Company.
Dr. Horne is an internationally regarded scientist that has led numerous scientific teams in the successful development and production of commercial human and animal health care products. Most recently, he held the position of Director of Research in the animal health division of Novartis AG. While... (4 KB) |
|
Wed Jun 11, 2008
Functional Technologies Announces National Research Council Contribution to Support Development of Proprietary Yeasts
VANCOUVER, BRITISH COLUMBIA - June 11, 2008 -- Functional Technologies Corp. (TSXV: FEB) is pleased to announce that the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) has provided a contribution for the Company's commercial development of its proprietary urea-degrading yeast products. With the anticipated launch of the Company's first proprietary yeasts, the NRC-IRAP contribution will be utilized to develop next generation yeast products to continuously im... (5 KB) |
|
Mon Jun 9, 2008
Functional Technologies Announces Participation in the 2008 Home Winemaking and Brewing Trade Association Annual Conference
VANCOUVER, BRITISH COLUMBIA --- June 9, 2008 --- Functional Technologies Corp. (TSXV: FEB) is pleased to announce the launch of its wholly owned subsidiary, Phyterra Yeast, Inc., at the 2008 Home Winemaking and Brewing Trade Association (HWBTA) Annual Conference in Baltimore, MD. Phyterra Yeast, Inc., formerly known as First Venture Yeast Products, will be responsible for Functional Technologies' ... (4 KB) |
|
Thu May 15, 2008
First Venture Announces Company Name Change to Functional Technologies Corp.
VANCOUVER, BRITISH COLUMBIA - May 15, 2008 - First Venture Technologies Corp. (TSXV: FEB) is pleased to announce that it will be changing its name to Functional Technologies Corp. The corporate name change reflects the company's strategic focus on developing proprietary functional foods and health care products.
"Functional foods is an important and emerging growth sector within the global food and beverage industry. Both consumer and health science community awareness of the health benefit... (3 KB) |
|
Wed May 14, 2008
First Venture Appoints Director of Investor Relations
VANCOUVER, BRITISH COLUMBIA --- May 14, 2008 --- First Venture Technologies Corp. (TSXV: FEB) is pleased to announce the appointment of Mr. Hogan Mullally as its Director of Investor Relations. Mr. Mullally will work with First Venture's senior management on the continued development and implementation of a thorough investor relations program to increase the company's capital market visibility.
Mr. Mullally brings nine years of pharmaceutical and life science industry experience to First Ven... (4 KB) |
| |
|
